Literature DB >> 19582813

Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes.

Herdis Bender1, Monique Y Wiesinger, Carolin Nordhoff, Caroline Schoenherr, Claude Haan, Stephan Ludwig, Ralf Weiskirchen, Nobuyuki Kato, Peter C Heinrich, Serge Haan.   

Abstract

UNLABELLED: Interleukin-27 (IL-27) is a cytokine belonging to the IL-6/IL-12 cytokine family. It is secreted by antigen-presenting cells, strongly acts on T cells, and also stimulates innate immune cells. In most studies, the effects of IL-27 on T cells were investigated; however, not much is known about possible effects of IL-27 on other cell types. IL-27 signals via the common IL-6-type cytokine receptor chain gp130 and the IL-27-specific chain WSX-1. Given the importance of gp130 in regulating liver responses such as the acute phase response or liver regeneration, we investigated whether IL-27 could also have a function in liver cells. We find that IL-27 stimulates hepatoma cells and hepatocytes by inducing a sustained signal transducer and activator of transcription (STAT)1 and STAT3 activation. Whereas the STAT3 mediated responses to IL-27 (gamma-fibrinogen and hepcidin induction) are not detectable, we observe an interferon-gamma (IFN-gamma)-like STAT1 response leading to the induction of interferon-regulated proteins such as STAT1, STAT2, interferon response factor (IRF)-1, IRF-9, myxovirus resistance A and guanylate binding protein 2.
CONCLUSION: Our study provides evidence for a function of IL-27 in hepatoma cells and hepatocytes and shows that IL-27 responses are not restricted to the classical immune cells. Our results suggest that IL-27 exerts IFN-like functions in liver cells and that it can contribute to the antiviral response in these cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582813     DOI: 10.1002/hep.22988

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication.

Authors:  Guangyun Tan; Qingfei Xiao; Hongxiao Song; Feng Ma; Fengchao Xu; Di Peng; Na Li; Xiaosong Wang; Junqi Niu; Pujun Gao; F Xiao-Feng Qin; Genhong Cheng
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

2.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

Review 3.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

4.  Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling.

Authors:  Li Liu; Zhongying Cao; Jing Chen; Rui Li; Yanhua Cao; Chengliang Zhu; Kailang Wu; Jianguo Wu; Fang Liu; Ying Zhu
Journal:  J Biol Chem       Date:  2012-02-16       Impact factor: 5.157

5.  Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus.

Authors:  Astrid C Frank; Xiaozhen Zhang; Antonios Katsounas; Jennifer P Bharucha; Shyamasundaran Kottilil; Tomozumi Imamichi
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

6.  Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses.

Authors:  Caroline Schoenherr; Ralf Weiskirchen; Serge Haan
Journal:  Cell Commun Signal       Date:  2010-08-19       Impact factor: 5.712

Review 7.  Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection.

Authors:  Sanjay Swaminathan; Lue Dai; H Clifford Lane; Tomozumi Imamichi
Journal:  Cytokine Growth Factor Rev       Date:  2013-08-17       Impact factor: 7.638

8.  Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.

Authors:  J F Yang; H Q Tao; Y M Liu; X X Zhan; Y Liu; X Y Wang; J H Wang; L L Mu; L L Yang; Z M Gao; Q F Kong; G Y Wang; J H Han; B Sun; H L Li
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

9.  Modulation of IL-27 in adipocytes during inflammatory stress.

Authors:  Heesun Nam; Bradley S Ferguson; Jacqueline M Stephens; Ron F Morrison
Journal:  Obesity (Silver Spring)       Date:  2015-12-06       Impact factor: 5.002

10.  Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.

Authors:  Fouad Lafdil; Hua Wang; Ogyi Park; Weici Zhang; Yuki Moritoki; Shi Yin; Xin Yuan Fu; M Eric Gershwin; Zhe-Xiong Lian; Bin Gao
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.